Oxford Clinical Trials Research Unit
We would like to make everyone aware that the OCTRU office continues to be contactable during the current situation regarding COVID-19.
If you have any queries please continue to contact us at firstname.lastname@example.org or for queries about specific trials, please contact the trial teams directly on the numbers on your information sheets or the trial websites.
Welcome to the OCTRU website. The University of Oxford has a long standing tradition in clinical trials and OCTRU based within the University is one of the UKCRC's registered clinical trials units.
15 November 2022
Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.
4 October 2022
Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.
Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury
23 August 2022
New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.
NIHR CTU SUPPORT
PLEASE NOTE: This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.
Recent OCTRU Publications
Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial.
Costa ML. et al, (2022), Bmj, 376
TRAINING SESSIONS & SEMINARS
Tuesday, 07 February 2023, 10am to 12pm
Would you like to collaborate with OCTRU?
OCTRU welcomes requests to collaborate, look to see which of our themes your collaboration may fit within.